This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Children's Medical Center Corporation, Beth Israel Deaconess Medical Center, Inc.. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,074 
1 out of 539 
Years Active: 2019-2025
Title: Alban A. Latremoliere: Innovator in Neuropathic Pain Research
Introduction
Alban A. Latremoliere is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of neuropathic pain research, holding 2 patents that focus on innovative methods for detection and treatment.
Latest Patents
Latremoliere's latest patents include groundbreaking work on biomarkers of neuropathic pain. This disclosure relates to methods of objectively detecting and measuring neuropathic pain in a subject. Additionally, he has developed methods and assays relating to sepiapterin reductase inhibition. These methods involve measuring the level of sepiapterin and can also relate to treating a subject with BH4 and/or BH2.
Career Highlights
Throughout his career, Latremoliere has worked with esteemed organizations such as Children's Medical Center Corporation and Beth Israel Deaconess Medical Center, Inc. His work has been pivotal in advancing the understanding of neuropathic pain and its treatment.
Collaborations
Latremoliere has collaborated with prominent figures in the field, including Clifford J. Woolf and Thomas E. Scammell. These collaborations have further enriched his research and contributions to medical science.
Conclusion
Alban A. Latremoliere stands out as an influential inventor in the realm of neuropathic pain research. His innovative patents and collaborations highlight his commitment to advancing medical knowledge and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile